Unique ID issued by UMIN | UMIN000018384 |
---|---|
Receipt number | R000021262 |
Scientific Title | Effects of AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Males Exposed by Ultraviolet in Daily Life |
Date of disclosure of the study information | 2015/07/23 |
Last modified on | 2016/05/10 11:18:30 |
Effects of AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Males Exposed by Ultraviolet in Daily Life
Effects of AVGP (Aloe Vera Gel Powder) for Skin Function
Effects of AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Males Exposed by Ultraviolet in Daily Life
Effects of AVGP (Aloe Vera Gel Powder) for Skin Function
Japan |
Skin function
Not applicable | Adult |
Others
NO
This study aims to evaluate efficacy of AVGP (Aloe Vera Gel Powder) for skin function of healthy adult males exposed by ultraviolet in daily life.
Efficacy
[1]Skin viscoelasticity
[2]Transepidermal water loss
[3]Water content of the skin
[4]Collagen score (measuring with ultrasonic waves)
[1]Observation for skin condition
[2]Subjective symptom for skin condition
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Oral ingestion of the test product (12 weeks)
Oral ingestion of the control product (12 weeks)
30 | years-old | <= |
60 | years-old | > |
Male
[1]Healthy Japanese males aged 30-60 years
[2]Individuals who are outside in the daytime for 2-5 hours
[1]Individuals who use regularly cosmetology or foods affecting to skin condition
[2]Individuals who have skin disease
[3]Individuals whose arm(s) have an abnormality requiring treatment
[4]Individuals who use regularly quasi-drugs, cosmetics, and creams
[5]Individuals who tan regularly at a tanning salon
[6]Individuals who contract allergic disease with sleep deprivation or sleep disorder
[7]Individuals who contract disease affecting to skin condition
[8]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day)
[9]Individuals who is a smoker (smoking over 20 cigarettes/day)
[10]Individuals who contract or have a history of serious skin disease, hepatopathy, kidney damage, heart disease, lung disease, endocrine disease, and metabolic disease
[11]Individuals who have a history of drug allergy or serious food allergy
[12]Individuals who participated in other clinical studies in the past three months
[13]Individuals judged inappropriate for the study by the principal by the results of subject background, physical findings, or medical examination
48
1st name | |
Middle name | |
Last name | Shuji Nakata |
Medical Corporation Bokushinkai CLINTEXE Clinic
Internal Department
4F Atago Green Hills Mori Tower 2-5-1 Atago Minato-ku Tokyo 105-6204, JAPAN
03-5405-1059
info@tes-h.co.jp
1st name | |
Middle name | |
Last name | Toshiyasu Tamura |
TES Holdings Co., Ltd
Department of Clinical Trial
6F University of Tokyo Entrepreneur Plaza 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033, JAPAN
03-6801-8480
info@tes-h.co.jp
TES Holdings Co., Ltd
Morinaga Milk Industry CO., Ltd.
Profit organization
Department of Dermatology, Wakayama Medical University
NO
2015 | Year | 07 | Month | 23 | Day |
Unpublished
Completed
2015 | Year | 07 | Month | 15 | Day |
2015 | Year | 07 | Month | 25 | Day |
2015 | Year | 07 | Month | 22 | Day |
2016 | Year | 05 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021262
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |